Lista de obras -

14th annual retrovirus conference (CROI). One-on-one with Joseph J. Eron, MD. Interview by Jeff Berry

artículo científico publicado en 2007

1768. Efficacy and Safety of Switching From Boosted-Protease Inhibitors (bPI) Plus Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) Regimens to the Once Daily (QD), Single-Tablet Regimen (STR) of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafen

2490. Longer-Term Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed Adults Living With HIV and End-Stage Renal Disease on Chronic Hemodialysis

2503. Differences Between Experts and Community Clinicians in Selecting HIV Switch Regimens for Patients With Viral Suppression

artículo científico publicado en 2019

3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine

artículo científico publicado en 2000

550. Adherence and Persistency With Modern Single vs. Multi-Tablet Antiretroviral (ARV) Regimens in First Treatment of HIV in Clinical Practice

article

A 42-week open-label study to assess the pharmacokinetics, antiretroviral activity, and safety of amprenavir or amprenavir plus ritonavir in combination with abacavir and lamivudine for treatment of HIV-infected patients

artículo científico publicado en 2004

A brief mental health and substance abuse screener for persons with HIV.

artículo científico publicado en 2005

A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II).

artículo científico publicado en 2000

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

artículo científico publicado en 1997

A novel codon insert in protease of clade B HIV type 1.

artículo científico publicado en 2009

A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy

artículo científico publicado en 2003

A phase II trial of dual protease inhibitor therapy: amprenavir in combination with indinavir, nelfinavir, or saquinavir

artículo científico publicado en 2001

A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease

artículo científico publicado en 2003

A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavir.

artículo científico publicado en 2003

A week 48 randomized phase 3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve HIV-1 patients.

artículo científico publicado en 2018

ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results.

artículo científico publicado en 2001

Aciclovir treatment for human immunodeficiency virus-1: is the “juice worth the squeeze?”.

artículo científico publicado en 2011

Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961).

artículo científico publicado en 2010

Activity, safety, and immunological effects of hydroxyurea added to didanosine in antiretroviral-naive and experienced HIV type 1-infected subjects: a randomized, placebo-controlled trial, ACTG 307.

artículo científico publicado en 2004

Acute HIV Infection and CD4/CD8 Ratio Normalization After Antiretroviral Therapy Initiation

artículo científico publicado en 2018

Acute HIV revisited: new opportunities for treatment and prevention

artículo científico publicado en 2004

Acute HIV revisited: new opportunities for treatment and prevention.

artículo científico publicado en 2006

Acute HIV-1 infection in the Southeastern United States: a cohort study

artículo científico publicado en 2012

Addition of 7 Days of Zidovudine Plus Lamivudine to Peripartum Single-Dose Nevirapine Effectively Reduces Nevirapine Resistance Postpartum in HIV-Infected Mothers in Malawi ⬇️

artículo científico publicado el 1 de agosto de 2010

Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

artículo científico publicado en 2012

Advanced immunosuppression at entry to HIV care in the southeastern United States and associated risk factors

scientific article published on 01 March 2006

Advances in antiretroviral therapy

African American race and HIV virological suppression: beyond disparities in clinic attendance

artículo científico publicado en 2014

Age at Entry Into Care, Timing of Antiretroviral Therapy Initiation, and 10-Year Mortality Among HIV-Seropositive Adults in the United States

artículo científico publicado en 2015

Age at antiretroviral therapy initiation predicts immune recovery, death, and loss to follow-up among HIV-infected adults in urban Zambia

artículo científico publicado en 2014

Age trends in the prevalence of cervical squamous intraepithelial lesions among HIV-positive women in Cameroon: a cross-sectional study

artículo científico publicado en 2012

Alternative strategies for anti-HIV treatment

artículo científico publicado en 2001

Amino-terminal alteration of the HLA-A*0201-restricted human immunodeficiency virus pol peptide increases complex stability and in vitro immunogenicity

artículo científico publicado en 1995

An HIV self-care symptom management intervention for African American mothers

artículo científico publicado en 2003

Analysis of BENCHMRK 1 & 2 using PhenoSense® assay for darunavir (DRV/r) resistance and exploration of functional monotherapy with RAL vs DRV.

artículo científico publicado en 2010

Analysis of virological efficacy in trials of antiretroviral regimens: drawbacks of not including viral load measurements after premature discontinuation of therapy

scientific article published on 01 December 2002

Anemia risk factors among people living with HIV across the United States in the current treatment era: a clinical cohort study

artículo científico publicado en 2020

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel

scientific article published on July 2016

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel

artículo científico publicado en 2018

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel

artículo científico publicado en 2020

Antiretroviral Therapy for the Prevention of HIV-1 Transmission

artículo científico publicado en 2016

Antiretroviral activity and safety of once-daily etravirine in treatment-naive HIV-infected adults: 48-week results

artículo científico publicado en 2015

Antiretroviral drug class and anaemia risk in the current treatment era among people living with HIV in the USA: a clinical cohort study

scientific article published on 19 March 2020

Antiretroviral drug resistance in HIV-1-infected patients experiencing persistent low-level viremia during first-line therapy

artículo científico publicado en 2011

Antiretroviral intensification and valproic acid lack sustained effect on residual HIV-1 viremia or resting CD4+ cell infection

artículo científico publicado en 2010

Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T-cell activation

artículo científico publicado en 2013

Antiretroviral therapy: new drugs, formulations, ideas, and strategies

artículo científico publicado en 2009

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel

artículo científico publicado en 2008

Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel.

artículo científico publicado en 2012

Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel.

artículo científico publicado en 2014

Antiretroviral-Drug Concentrations in Semen: Implications for Sexual Transmission of Human Immunodeficiency Virus Type 1.

artículo científico publicado en 2000

Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1

artículo científico publicado en 1999

Assessing and Refining Myocardial Infarction Risk Estimation Among Patients With Human Immunodeficiency Virus: A Study by the Centers for AIDS Research Network of Integrated Clinical Systems

artículo científico publicado en 2016

Assessing the impact of AGS-004, a dendritic cell-based immunotherapy, and vorinostat on persistent HIV-1 Infection

artículo científico publicado en 2020

Association Between Bilirubin, Atazanavir, and Cardiovascular Disease Events Among People Living With HIV Across the United States

artículo científico publicado en 2019

Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data

artículo científico publicado en 2014

Association between first-year virological response to raltegravir and long-term outcomes in treatment-experienced patients with HIV-1 infection

artículo científico publicado en 2014

Association of CD4 cell depletion and elevated blood and seminal plasma human immunodeficiency virus type 1 (HIV-1) RNA concentrations with genital ulcer disease in HIV-1-infected men in Malawi

artículo científico publicado en 1998

Association of early HIV viremia with mortality after HIV-associated lymphoma

artículo científico publicado en 2013

Association of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected subjects with prior nucleoside analog experience

artículo científico publicado en 2008

Associations Between At-Risk Alcohol Use, Substance Use, and Smoking with Lipohypertrophy and Lipoatrophy Among Patients Living with HIV.

artículo científico publicado en 2017

Associations of T cell activation and inflammatory biomarkers with virological response to darunavir/ritonavir plus raltegravir therapy

artículo científico publicado en 2013

Attrition among human immunodeficiency virus (HIV)- infected patients initiating antiretroviral therapy in China, 2003-2010

artículo científico publicado en 2012

Barriers and facilitators to HIV testing and linkage to primary care: narratives of people with advanced HIV in the Southeast

artículo científico publicado en 2009

Beyond core indicators of retention in HIV care: missed clinic visits are independently associated with all-cause mortality

artículo científico publicado en 2014

Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events

artículo científico publicado en 2018

Brief Report: HIV Antibodies Decline During Antiretroviral Therapy but Remain Correlated With HIV DNA and HIV-Specific T-Cell Responses

artículo científico publicado en 2019

Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial

artículo científico publicado en 2016

Brief Report: Longitudinal Opioid Use Among HIV-Infected Patients, 2000 to 2014.

artículo científico publicado en 2017

Brief Report: No Evidence for an Association Between Statin Use and Lower Biomarkers of HIV Persistence or Immune Activation/Inflammation During Effective ART

scientific article published on 01 October 2019

Brief Report: Reduced Use of Illicit Substances, Even Without Abstinence, Is Associated With Improved Depressive Symptoms Among People Living With HIV

scientific article published on 01 November 2018

Brief Report: Virologic Response by Baseline Viral Load With Dolutegravir Plus Lamivudine vs Dolutegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine: Pooled Analysis

artículo científico publicado en 2020

Brief but efficient: acute HIV infection and the sexual transmission of HIV.

artículo científico publicado en 2004

CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals

artículo científico publicado en 2008

CD4 count at entry into HIV care and at antiretroviral therapy prescription in the US, 2005-2018

scientific article published on 31 December 2020

CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?

artículo científico publicado en 2010

CD4+CD8+ T cells represent a significant portion of the anti-HIV T cell response to acute HIV infection

artículo científico publicado en 2012

Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

artículo científico publicado en 2021

Cabotegravir is Not Associated with Weight Gain in HIV-uninfected Individuals in HPTN 077.

artículo científico publicado en 2019

Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trial

artículo científico publicado en 2015

Cancer risk in HIV patients with incomplete viral suppression after initiation of antiretroviral therapy.

artículo científico publicado en 2018

Cervical cancer epidemiology among HIV-infected women in North America.

artículo científico publicado en 2010

Chagasic encephalitis as the initial manifestation of AIDS

article

Changes in Clinical Context for Kaposi's Sarcoma and Non-Hodgkin Lymphoma Among People With HIV Infection in the United States

artículo científico publicado en 2016

Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy

artículo científico publicado en 2000

Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants.

artículo científico publicado en 1999

Characterizing the Human Immunodeficiency Virus Care Continuum Among Transgender Women and Cisgender Women and Men in Clinical Care: A Retrospective Time-series Analysis

artículo científico publicado en 2020

Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy

artículo científico publicado en 2017

Clinical characteristics and early outcomes in patients with COVID-19 treated with tocilizumab at a United States academic center

artículo científico publicado en 2020

Clinical effectiveness of integrase strand transfer inhibitor-based antiretroviral regimens among adults with human immunodeficiency virus: a collaboration of cohort studies in the United States and Canada

artículo científico publicado en 2020

Clinical presentation, treatment, and outcomes among 65 patients with HIV-associated lymphoma treated at the University of North Carolina, 2000-2010

artículo científico publicado en 2011

Clonal sequences recovered from plasma from patients with residual HIV-1 viremia and on intensified antiretroviral therapy are identical to replicating viral RNAs recovered from circulating resting CD4+ T cells

artículo científico publicado en 2011

Clones of infected cells arise early in HIV-infected individuals

artículo científico publicado en 2019

Coadministration of lopinavir/ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 induction

artículo científico publicado en 2004

Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).

artículo científico publicado en 2007

Comparative effectiveness of fish oil versus fenofibrate, gemfibrozil, and atorvastatin on lowering triglyceride levels among HIV-infected patients in routine clinical care

artículo científico publicado en 2013

Comparing neighborhood and state contexts for women living with and without HIV: understanding the Southern HIV epidemic

artículo científico publicado en 2018

Comparison of NucliSens and Roche Monitor assays for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma

artículo científico publicado en 1999

Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study

artículo científico publicado en 2017

Comparison of illumina and 454 deep sequencing in participants failing raltegravir-based antiretroviral therapy

artículo científico publicado en 2014

Comparison of two indinavir/ritonavir regimens in the treatment of HIV-infected individuals

artículo científico publicado en 2004

Continued Slow Decay of the Residual Plasma Viremia Level in HIV-1-Infected Adults Receiving Long-term Antiretroviral Therapy

artículo científico publicado en 2015

Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Trials Group protocol 370.

artículo científico publicado en 2000

Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies

article

Copy-years viremia as a measure of cumulative human immunodeficiency virus viral burden

artículo científico publicado en 2009

Correction: The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial.

artículo científico publicado en 2011

Correlation between self-reported adherence to highly active antiretroviral therapy (HAART) and virologic outcome

artículo científico publicado en 2001

Correspondence between the effect of zidovudine plus lamivudine on plasma HIV level/CD4 lymphocyte count and the incidence of clinical disease in infected individuals. North American Lamivudine HIV Working Group

artículo científico publicado en 1997

Cross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapy

artículo científico publicado en 2011

Cumulative Antiretroviral Exposure Measured in Hair Is Not Associated With Measures of HIV Persistence or Inflammation Among Individuals on Suppressive ART.

artículo científico publicado en 2018

Cumulative human immunodeficiency viremia, antiretroviral therapy, and incident myocardial infarction

artículo científico publicado en 2019

Curing HIV: Seeking to Target and Clear Persistent Infection

artículo científico publicado en 2020

Current and Past Immunodeficiency are Associated with Higher Hospitalization Rates among Persons on Virologically Suppressive Antiretroviral Therapy for up to Eleven Years

artículo científico publicado en 2020

Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-experienced, virologically suppressed patients with HIV-1: subgroup analyses of the phase 3 EMERALD study

artículo científico publicado en 2019

Decreasing excess mortality of HIV-infected patients initiating antiretroviral therapy: comparison with mortality in general population in China, 2003-2009

scientific article published on August 2013

Detectable HIV-1 RNA at levels below quantifiable limits by amplicor HIV-1 monitor is associated with virologic relapse on antiretroviral therapy

artículo científico publicado en 1999

Detection and biologic characterization of infectious HIV-1 in semen of seropositive men

scientific article published on 01 September 1994

Detection of acute infections during HIV testing in North Carolina.

artículo científico publicado en 2005

Determination of amprenavir, a HIV-1 protease inhibitor, in human seminal plasma using high-performance liquid chromatography-tandem mass spectrometry

artículo científico publicado en 2002

Differential CD4+ cell count increase and CD4+ : CD8+ ratio normalization with maraviroc compared with tenofovir.

artículo científico publicado en 2016

Differentiation of Type 1 and Type 2 Myocardial Infarctions Among HIV-Infected Patients Requires Adjudication Due to Overlap in Risk Factors

artículo científico publicado en 2018

Discontinuation rates for protease inhibitor regimens containing ritonavir 600 mg versus ritonavir 400 mg plus saquinavir 400 mg.

artículo científico publicado en 1999

Diversity and Tropism of HIV-1 Rebound Virus Populations in Plasma Level After Treatment Discontinuation

artículo científico publicado en 2016

Does HAART efficacy translate to effectiveness? Evidence for a trial effect

artículo científico publicado en 2011

Dolutegravir efficacy at 48 weeks in key subgroups of treatment-naive HIV-infected individuals in three randomized trials.

artículo científico publicado en 2015

Dose separation does not overcome the pharmacokinetic interaction between fosamprenavir and lopinavir/ritonavir

artículo científico publicado en 2006

Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients.

artículo científico publicado en 1996

Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trial

artículo científico publicado en 2002

Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 versus optimized background regimen only 1 and 2 clinical trials

artículo científico publicado en 2005

Dynamic Visual Display of Treatment Response in HIV-Infected Adults

artículo científico publicado en 2015

Effect of antiviral treatment on the shedding of HIV-1 in semen ⬇️

artículo científico publicado el 1 de agosto de 1997

Effect of early versus deferred antiretroviral therapy for HIV on survival

artículo científico publicado en 2009

Effect of hepatitis C coinfection on discontinuation and modification of initial HAART in primary HIV care

artículo científico publicado en 2006

Effect of hydroxyurea and dideoxyinosine on intracellular 3'-deoxyadenosine-5'-triphosphate concentrations in HIV-infected patients

artículo científico publicado en 2007

Effect of pulmonary tuberculosis on mortality in patients receiving HAART.

artículo científico publicado en 2009

Effectiveness of integrase strand transfer inhibitors among treatment-experienced patients in a clinical setting

artículo científico publicado en 2019

Effects of Health Insurance Interruption on Loss of Hypertension Control in Women With and Women Without HIV.

artículo científico publicado en 2017

Effects of Reverse Transcriptase Inhibitor Therapy on the HIV-1 Viral Burden in Semen ⬇️

artículo científico publicado el 1 de mayo de 1997

Effects of age and sex on immunological and virological responses to initial highly active antiretroviral therapy

artículo científico publicado en 2007

Effects of combination antiretroviral therapies on the risk of myocardial infarction among HIV patients

artículo científico publicado en 2014

Effects of early human immunodeficiency virus infection on cerebral white matter blood flow autoregulation

artículo científico publicado en 2022

Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial

artículo científico publicado en 2014

Effects of formulation and dosing strategy on amprenavir concentrations in the seminal plasma of human immunodeficiency virus type 1-infected men.

artículo científico publicado en 2002

Effects of genital tract inflammation on human immunodeficiency virus type 1 V3 populations in blood and semen

artículo científico publicado en 2000

Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials

artículo científico publicado en 2013

Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically

artículo científico publicado en 2017

Efficacy of NNRTI-based antiretroviral therapy initiated during acute HIV infection

artículo científico publicado en 2011

Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262).

artículo científico publicado en 2011

Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection.

artículo científico publicado en 2000

Elevated AST-to-platelet ratio index is associated with increased all-cause mortality among HIV-infected adults in Zambia

artículo científico publicado en 2015

Emergence of HIV drug resistance during first- and second-line antiretroviral therapy in resource-limited settings

artículo científico publicado en 2013

Emergence of dual resistance to zidovudine and lamivudine in HIV-1-infected patients treated with zidovudine plus lamivudine as initial therapy

artículo científico publicado en 2000

Emotional distress in African American women with HIV.

artículo científico publicado en 2007

Emulating a trial of joint dynamic strategies: An application to monitoring and treatment of HIV-positive individuals

artículo científico publicado en 2019

End-stage renal disease among HIV-infected adults in North America

artículo científico publicado en 2014

Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America

artículo científico publicado en 2003

Enrollment, Retention, and Visit Attendance in the University of North Carolina Center for AIDS Research HIV Clinical Cohort, 2001–2007 ⬇️

artículo científico publicado el 1 de agosto de 2010

Envelope diversity, coreceptor usage and syncytium-inducing phenotype of HIV-1 variants in saliva and blood during primary infection ⬇️

artículo científico publicado el 26 de septiembre de 2003

Erratum

scholarly article published in Pharmacology & Therapeutics

Erratum: Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

artículo científico publicado en 2012

Erratum: Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy

scientific article published in Nature

Estimating Human Immunodeficiency Virus (HIV) Prevention Effects in Low-incidence Settings

scientific article published on 01 May 2019

Estimating a set of mortality risk functions with multiple contributing causes of death

artículo científico publicado en 2020

Estimating multiple time-fixed treatment effects using a semi-Bayes semiparametric marginal structural Cox proportional hazards regression model.

artículo científico publicado en 2017

Estimation of the standardized risk difference and ratio in a competing risks framework: application to injection drug use and progression to AIDS after initiation of antiretroviral therapy

artículo científico publicado en 2014

Evaluating nurses' implementation of an infant-feeding counseling protocol for HIV-infected mothers: The Ban Study in Lilongwe, Malawi

artículo científico publicado en 2009

Evaluating the Effect of Early Versus Late ARV Regimen Change if Failure on an Initial Regimen: Results From the AIDS Clinical Trials Group Study A5095.

artículo científico publicado en 2012

Evaluating the Efficacy of Therapies in COVID-19 Patients

artículo científico publicado en 2020

Evaluating the Population Impact of Intervening on Specific Targets to Reduce HIV Racial/Ethnic Disparities in Adulthood: a Conceptual and Methodological Framework

artículo científico publicado en 2017

Evaluating the incident user design in the HIV population: incident use versus naive?

artículo científico publicado en 2014

Evaluation of the impact of highly active antiretroviral therapy on immune recovery in antiretroviral naive patients

artículo científico publicado en 2004

Evidence for risk stratification when monitoring for toxicities following initiation of combination antiretroviral therapy

artículo científico publicado en 2013

Evidence of Ongoing Immune Reconstitution in Subjects with Sustained Viral Suppression following 6 Years of Lopinavir-Ritonavir Treatment

article

Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068

scientific article published on 01 August 2006

Evolution of HIV-1 drug resistance after virological failure of first-line antiretroviral therapy in Lusaka, Zambia

scientific article published on 01 January 2019

Expert offers help for PI-related heart disease.

artículo científico publicado en 2002

Expression of p16(INK4a) as a biomarker of T-cell aging in HIV-infected patients prior to and during antiretroviral therapy

artículo científico publicado en 2012

Factors associated with changes in HIV shedding in semen

scientific article published on 01 April 1998

Factors associated with delayed hepatitis B viral suppression on tenofovir among patients coinfected with HBV-HIV in the CNICS cohort

artículo científico publicado en 2014

Factors associated with fewer visits for HIV primary care at a tertiary care center in the Southeastern U.S.

scientific article published on 01 January 2006

Failure of lopinavir-ritonavir (Kaletra)-containing regimen in an antiretroviral-naive patient

artículo científico publicado en 2004

Female genital tract shedding of HIV-1 is rare in women with suppressed HIV-1 in plasma

scientific article published on 01 January 2020

Fixed-dose combination emtricitabine/tenofovir/efavirenz initiated during acute HIV infection; 96-week efficacy and durability.

artículo científico publicado en 2016

Frequent detection of acute HIV infection in pregnant women

artículo científico publicado en 2007

Frequent detection of acute primary HIV infection in men in Malawi

artículo científico publicado en 2004

Gender difference in HIV RNA levels: a meta-analysis of published studies

scientific article published on 01 September 2002

Generalizing Evidence from Randomized Trials using Inverse Probability of Sampling Weights

scientific article published on 26 February 2018

Genetic architecture of cardiometabolic risks in people living with HIV

artículo científico publicado en 2020

Genetic basis for variation in plasma IL-18 levels in persons with chronic hepatitis C virus and human immunodeficiency virus-1 infections

artículo científico publicado en 2017

Genotypic and phenotypic characterization of HIV-1 isolates obtained from patients on rilpivirine therapy experiencing virologic failure in the phase 3 ECHO and THRIVE studies: 48-week analysis

scientific article published on 01 January 2012

Genotypic resistance and the treatment of HIV-1 infection in Espírito Santo, Brazil

artículo científico publicado en 1999

HIV Care Initiation Delay among Rural Residents in the Southeastern United States, 1996 to 2012.

artículo científico

HIV Infection, Immunosuppression, and Age at Diagnosis of Non-AIDS-Defining Cancers

artículo científico publicado en 2016

HIV Salvage Therapy Does Not Require Nucleoside Reverse Transcriptase Inhibitors: A Randomized, Controlled Trial.

artículo científico publicado en 2015

HIV Transmission Patterns Among Immigrant Latinos Illuminated by the Integration of Phylogenetic and Migration Data

artículo científico publicado en 2015

HIV Viral Suppression Trends Over Time Among HIV-Infected Patients Receiving Care in the United States, 1997 to 2015: A Cohort Study.

artículo científico publicado en 2018

HIV antigens can induce TGF-beta(1)-producing immunoregulatory CD8+ T cells

artículo científico publicado en 2002

HIV cure strategies: how good must they be to improve on current antiretroviral therapy?

artículo científico publicado en 2014

HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health

artículo científico publicado en 2001

HIV primary care providers--Screening, knowledge, attitudes and behaviors related to alcohol interventions

artículo científico publicado en 2016

HIV risk behaviors and sociodemographic features of HIV-infected Latinos residing in a new Latino settlement area in the Southeastern United States

artículo científico publicado en 2013

HIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapy

artículo científico publicado en 2014

HIV-1 Protease, Reverse Transcriptase, and Integrase Variation

artículo científico publicado en 2016

HIV-1 RNA levels and the development of clinical disease. North American Lamivudine HIV Working Group

artículo científico publicado en 1996

HIV-1 drug resistance evolution among patients on potent combination antiretroviral therapy with detectable viremia.

artículo científico publicado en 2005

HIV-1 expression within resting CD4+ T cells after multiple doses of vorinostat

artículo científico publicado en 2014

HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patients

artículo científico publicado en 2002

HIV-1 protease inhibitors

artículo científico publicado en 2000

HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 study

artículo científico publicado en 2011

HIV-1 shedding and chlamydial urethritis

artículo científico publicado en 1996

HIV-1 viral load and phenotypic antiretroviral drug resistance assays based on reverse transcriptase activity in comparison to amplification based HIV-1 RNA and genotypic assays

artículo científico publicado en 2009

HIV-1 viral load in blood, semen and saliva

artículo científico publicado en 1997

HIV-Specific, Ex Vivo Expanded T Cell Therapy: Feasibility, Safety, and Efficacy in ART-Suppressed HIV-Infected Individuals

article

HIV-specific T-cell responses reflect substantive in vivo interactions with antigen despite long-term therapy

artículo científico publicado en 2021

Health Insurance Type and Control of Hypertension Among US Women Living With and Without HIV Infection in the Women's Interagency HIV Study

artículo científico publicado en 2017

Hematologic, hepatic, renal, and lipid laboratory monitoring after initiation of combination antiretroviral therapy in the United States, 2000-2010.

artículo científico publicado en 2013

Hepatic safety and tolerability of raltegravir among HIV patients coinfected with hepatitis B and/or C

artículo científico publicado en 2014

Hepatitis C Virus (HCV) NS3 sequence diversity and antiviral resistance-associated variant frequency in HCV/HIV coinfection

artículo científico publicado en 2014

High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men.

artículo científico publicado en 2010

High clade C HIV-1 viremia: how did we get here and where are we going?

artículo científico publicado en 2011

High levels of antiretroviral use and viral suppression among persons in HIV care in the United States, 2010.

artículo científico publicado en 2013

High levels of human immunodeficiency virus type 1 in blood and semen of seropositive men in sub-Saharan Africa

artículo científico publicado en 1998

High prevalence of cervical squamous intraepithelial lesions in women on antiretroviral therapy in Cameroon: Is targeted screening feasible?

artículo científico publicado en 2012

High-dose lopinavir/ritonavir in highly treatment-experienced HIV-1 patients: efficacy, safety, and predictors of response

scientific article published on 01 July 2007

Hiv Drug Resistance in Adults Receiving Early Versus Delayed Antiretroviral Therapy: Hptn 052.

artículo científico publicado en 2017

Hospitalization Rates and Causes among Persons with HIV in the US and Canada, 2005-2015

artículo científico publicado en 2020

Hospitalization Rates and Outcomes among Persons Living with HIV in the Southeastern United States, 1996-2016

artículo científico publicado en 2019

How researchers define vulnerable populations in HIV/AIDS clinical trials

artículo científico publicado en 2010

Human Immunodeficiency Virus Type 1 Phylodynamics to Detect and Characterize Active Transmission Clusters in North Carolina

artículo científico publicado en 2020

Human Immunodeficiency Virus Type 1 RNA Detected in the Central Nervous System (CNS) After Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells

artículo científico publicado en 2019

Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors

artículo científico publicado en 1999

Hyper-excretion of human immunodeficiency virus type 1 RNA in saliva

artículo científico publicado en 2001

Hypertension Among HIV-infected Patients in Clinical Care, 1996-2013.

artículo científico publicado en 2016

Identifying HIV care enrollees at-risk for cannabis use disorder.

artículo científico publicado en 2016

Idiopathic thrombocytopenia purpura: Treatment patterns and an analysis of cost associated with intravenous immunoglobulin and anti-D therapy

artículo científico publicado en 1998

Illustration of a measure to combine viral suppression and viral rebound in studies of HIV therapy

artículo científico publicado en 2015

Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection

artículo científico publicado en 2012

Immune activation and plasma viral load in HIV-infected African individuals

artículo científico publicado en 1999

Immunogenicity of AGS-004 Dendritic Cell Therapy in Patients Treated During Acute HIV Infection

artículo científico publicado en 2017

Immunosuppression, hepatitis C infection, and acute renal failure in HIV-infected patients

artículo científico publicado en 2006

Impact of Health Insurance, ADAP, and Income on HIV Viral Suppression Among US Women in the Women's Interagency HIV Study, 2006-2009.

artículo científico publicado en 2016

Impact of abstinence and of reducing illicit drug use without abstinence on HIV viral load

article

Impact of biological sex on immune activation and frequency of the latent HIV reservoir during suppressive antiretroviral therapy

artículo científico publicado en 2020

Improving health outcomes among individuals with HIV, mental illness, and substance use disorders in the Southeast.

artículo científico publicado en 2006

Incidence and clinical features of cerebrovascular disease among HIV-infected adults in the Southeastern United States.

artículo científico publicado en 2013

Incidence and etiology of acute renal failure among ambulatory HIV-infected patients.

artículo científico publicado en 2005

Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy

artículo científico publicado en 2013

Incident AIDS or Death After Initiation of Human Immunodeficiency Virus Treatment Regimens Including Raltegravir or Efavirenz Among Adults in the United States

artículo científico publicado en 2017

Incident sexually transmitted infection as a biomarker for high-risk sexual behavior after diagnosis of acute HIV

artículo científico publicado en 2014

Incomplete viral suppression and mortality in HIV patients after antiretroviral therapy initiation

artículo científico publicado en 2017

Increased Cortical Cerebral Blood Flow in Asymptomatic Human Immunodeficiency Virus-Infected Subjects

artículo científico publicado en 2016

Increased Persistence of Initial Treatment for HIV Infection With Modern Antiretroviral Therapy

artículo científico publicado en 2017

Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population

artículo científico publicado en 2017

Indinavir, nevirapine, stavudine, and lamivudine for human immunodeficiency virus-infected, amprenavir-experienced subjects: AIDS Clinical Trials Group protocol 373.

artículo científico publicado en 2001

Influence of Substance Use Disorders on 2-Year HIV Care Retention in the United States

artículo científico publicado en 2017

Infrequent diagnosis of primary human immunodeficiency virus infection: missed opportunities in acute care settings

artículo científico publicado en 2003

Inhibition of Human Immunodeficiency Virus Type 1 Replication In Vitro by the Bisheteroarylpiperzine Atevirdine (U-87201E) in Combination with Zidovudine or Didanosine ⬇️

artículo científico publicado el 1 de agosto de 1993

Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia

artículo científico publicado en 2008

Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latency

artículo científico publicado en 2017

Intracellular nucleoside triphosphate concentrations in HIV-infected patients on dual nucleoside reverse transcriptase inhibitor therapy.

artículo científico publicado en 2007

Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study

artículo científico publicado en 2013

Investigating a sexual network of black men who have sex with men: implications for transmission and prevention of HIV infection in the United States

artículo científico publicado en 2012

Joint effects of alcohol consumption and high-risk sexual behavior on HIV seroconversion among men who have sex with men

artículo científico publicado en 2013

LB9. The Effect of Initiating Integrase Inhibitor-based vs. Non-Nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy on Progression to Diabetes among North American Persons in HIV Care

artículo científico publicado en 2019

Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial

article

Large scale screening of human sera for HCV RNA and GBV-C RNA.

artículo científico publicado en 2013

Late entry to HIV care among Latinos compared with non-Latinos in a southeastern US cohort

artículo científico publicado en 2011

Late presentation for human immunodeficiency virus care in the United States and Canada.

artículo científico publicado en 2010

Less Bone Loss With Maraviroc- Versus Tenofovir-Containing Antiretroviral Therapy in the AIDS Clinical Trials Group A5303 Study

artículo científico publicado en 2015

Lessons learned from the design and implementation of myocardial infarction adjudication tailored for HIV clinical cohorts

scientific article published on 11 March 2014

Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation.

artículo científico publicado en 2017

Leveraging Phylogenetics to Understand HIV Transmission and Partner Notification Networks

artículo científico publicado en 2018

Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

artículo científico publicado en 2017

Long-term Outcomes in a Large Randomized Trial of HIV-1 Salvage Therapy: 96-Week Results of AIDS Clinical Trials Group A5241 (OPTIONS)

artículo científico publicado en 2020

Long-term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modification

artículo científico publicado en 2008

Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trials

artículo científico publicado en 2010

Long-term efficacy and safety of the HIV integrase inhibitor raltegravir in patients with limited treatment options in a Phase II study.

artículo científico publicado en 2010

Long-term safety and durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients: 4 year follow-up study

artículo científico publicado en 2004

Longitudinal dynamics of intact HIV proviral DNA and outgrowth virus frequencies in a cohort of ART-treated individuals

artículo científico publicado en 2020

Lopinavir/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers

artículo científico publicado en 2006

Loss of infectivity ex vivo in plasma of human immunodeficiency virus-infected patients correlates with a high CD4 cell count.

artículo científico publicado en 1993

Loss to clinic and five-year mortality among HIV-infected antiretroviral therapy initiators

artículo científico publicado en 2014

Low prevalence of antiretroviral resistance among HIV type 1-positive prisoners in the Southeast United States

artículo científico publicado en 2012

Lymphoma immune reconstitution inflammatory syndrome in the center for AIDS research network of integrated clinical systems cohort

artículo científico publicado en 2014

Macrophages sustain HIV replication in vivo independently of T cells

artículo científico publicado en 2016

Major coexisting human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization ⬇️

artículo científico publicado en 2009

Male sex and obesity are associated with residual plasma HIV-1 viremia in persons on long-term antiretroviral therapy

scientific article published on 30 June 2020

Managing antiretroviral therapy: changing regimens, resistance testing, and the risks from structured treatment interruptions

artículo científico publicado en 2008

Massive CD8 T cell response to primary HIV infection in the setting of severe clinical presentation

Maximizing sensitivity and specificity of PCR by preamplification heating ⬇️

artículo científico publicado el 11 de julio de 1991

Meta-analysis of randomized trials on the association of prophylactic acyclovir and HIV-1 viral load in individuals coinfected with herpes simplex virus-2.

artículo científico publicado en 2011

Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america

artículo científico publicado en 2011

Modeling clinical endpoints as a function of time of switch to second-line ART with incomplete data on switching times

artículo científico publicado en 2013

Modeling long-term HIV dynamics and antiretroviral response: effects of drug potency, pharmacokinetics, adherence, and drug resistance.

artículo científico publicado en 2005

Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS)

artículo científico publicado en 2019

Moving forward in HIV-associated cancer.

scientific article published on 18 February 2014

Multiple Imputation to Account for Measurement Error in Marginal Structural Models

artículo científico publicado en 2015

Multiple V1/V2 env variants are frequently present during primary infection with human immunodeficiency virus type 1

artículo científico publicado en 2004

Narrative Solutions: Using Preferred View of Self to Motivate Individual and Family Change

artículo científico publicado en 2016

Natural Killer Cell Receptors and Ligands Are Associated With Markers of HIV-1 Persistence in Chronically Infected ART Suppressed Patients

artículo científico publicado en 2022

Naïve T Cells Are Maintained in the Periphery During the First3 Months of Acute HIV-1 Infection: Implications for Analysis of Thymus Function

article

Near Real-Time Identification of Recent HIV Transmissions, Transmitted Drug Resistance Mutations, and Transmission Networks by MPID-NGS in North Carolina

artículo científico publicado en 2020

Neighborhood Poverty and Control of HIV, Hypertension, and Diabetes in the Women's Interagency HIV Study

scientific article published on 06 January 2020

Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection

artículo científico publicado en 2001

Neurocognition with maraviroc compared with tenofovir in HIV.

artículo científico publicado en 2016

Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection

artículo científico publicado en 2006

New anti-HIV-1 therapies and combinations: current data and prospects.

artículo científico publicado en 1990

New antiretroviral agent use affects prevalence of HIV drug resistance in clinical care populations

artículo científico publicado en 2018

No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapy

artículo científico publicado en 2012

No evidence for decay of the latent reservoir in HIV-1-infected patients receiving intensive enfuvirtide-containing antiretroviral therapy

artículo científico publicado en 2010

Not all non-drinkers with HIV are equal: demographic and clinical comparisons among current non-drinkers with and without a history of prior alcohol use disorders

artículo científico publicado en 2016

Novel Criteria for Diagnosing Acute and Early HIV Infection in a Multi-National Study of Early Antiretroviral Therapy Initiation

scientific article published on 31 December 2020

Novel therapies based on mechanisms of HIV-1 cell entry.

artículo científico publicado en 2003

Nucleoside analogues achieve high concentrations in seminal plasma: relationship between drug concentration and virus burden

artículo científico publicado en 1999

Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial

artículo científico

Once-daily versus twice-daily lopinavir/ritonavir in antiretroviral-naive HIV-positive patients: a 48-week randomized clinical trial

artículo científico publicado en 2004

Ongoing HIV Transmission and the HIV Care Continuum in North Carolina

artículo científico publicado en 2015

Opioid misuse among persons with HIV engaged in care in the Southeastern US

scientific article published on 08 December 2019

Opportunities for sexual transmission of antiretroviral drug resistance among HIV-infected patients in care

artículo científico publicado en 2013

Oral hairy leukoplakia and oral candidiasis as predictors of HIV viral load

artículo científico publicado en 1999

Oral manifestations of HIV in a southeast USA population.

artículo científico publicado en 1998

Outcomes of second combination antiretroviral therapy regimens among HIV-infected persons in clinical care: a multicenter cohort study

artículo científico publicado en 2012

Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015.

artículo científico publicado en 2018

Perceived oral health status, unmet needs, and barriers to dental care among HIV/AIDS patients in a North Carolina cohort: impacts of race.

artículo científico publicado en 2003

Performance characteristics of the Cavidi ExaVir viral load assay and the ultra-sensitive P24 assay relative to the Roche Monitor HIV-1 RNA assay ⬇️

artículo científico publicado el 15 de septiembre de 2010

Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance

scientific article published on 15 July 2019

Persistent antiretroviral activity of nucleoside analogues after prolonged zidovudine and lamivudine therapy as demonstrated by rapid loss of activity after discontinuation

artículo científico publicado en 2004

Pharmacodynamics of antiretroviral agents in HIV-1 infected patients: using viral dynamic models that incorporate drug susceptibility and adherence.

artículo científico publicado en 2006

Pharmacokinetic and pharmacodynamic investigation of efavirenz in the semen and blood of human immunodeficiency virus type 1-infected men.

artículo científico publicado en 2002

Pharmacokinetic study of human immunodeficiency virus protease inhibitors used in combination with amprenavir

artículo científico publicado en 2001

Pharmacokinetics and pharmacodynamics of once-daily versus twice-daily raltegravir in treatment-naive HIV-infected patients

artículo científico publicado en 2012

Pharmacokinetics of lamivudine administered alone and with trimethoprim-sulfamethoxazole

scientific article published on 01 May 1996

Phylogenetic evidence of HIV-1 sequence evolution in subjects with persistent low-level viraemia

artículo científico publicado en 2014

Phylogenetic insights into regional HIV transmission

artículo científico publicado en 2012

Physical activity trends and metabolic health outcomes in people living with HIV in the US, 2008-2015

scientific article published on 12 February 2020

Pilot study demonstrating effectiveness of targeted education to improve informed consent understanding in AIDS clinical trials.

artículo científico publicado en 2011

Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection

artículo científico publicado en 2009

Poorly Controlled HIV Infection: An Independent Risk Factor for Liver Fibrosis

artículo científico publicado en 2016

Population pharmacokinetics of lamivudine in adult human immunodeficiency virus-infected patients enrolled in two phase III clinical trials

artículo científico publicado en 1999

Postpartum HIV care continuum outcomes in the southeastern USA

scientific article published on 01 March 2019

Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study

artículo científico publicado en 2000

Potential impact of antiretroviral therapy and screening on cervical cancer mortality in HIV-positive women in sub-Saharan Africa: a simulation

artículo científico publicado en 2011

Pre-exposure prophylaxis and antiretroviral resistance: HIV prevention at a cost?

artículo científico publicado en 2011

Pre-treatment integrase strand transfer inhibitor resistance in north carolina from 2010-2016.

artículo científico

Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies

artículo científico publicado en 2015

Predicting Efavirenz Concentrations in the Brain Tissue of HIV-Infected Individuals and Exploring their Relationship to Neurocognitive Impairment

article

Predicting resistance as indicator for need to switch from first-line antiretroviral therapy among patients with elevated viral loads: development of a risk score algorithm

artículo científico publicado en 2016

Prediction of HIV Transmission Cluster Growth With Statewide Surveillance Data

scientific article published on 01 February 2019

Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis

artículo científico publicado en 2013

Predictive value of pharmacokinetics-adjusted phenotypic susceptibility on response to ritonavir-enhanced protease inhibitors (PIs) in human immunodeficiency virus-infected subjects failing prior PI therapy

artículo científico publicado en 2009

Predictors of residual viraemia in patients on long-term suppressive antiretroviral therapy

artículo científico publicado en 2012

Prevalence and Factors Associated with Hazardous Alcohol Use Among Persons Living with HIV Across the US in the Current Era of Antiretroviral Treatment

artículo científico publicado en 2017

Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States

artículo científico publicado en 2016

Prevalence and Transmission Dynamics of HIV-1 Transmitted Drug Resistance in a Southeastern Cohort

scientific article published on 20 July 2018

Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV+ patient population

artículo científico publicado en 2008

Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States

artículo científico publicado en 2006

Prevalence of transmitted antiretroviral drug resistance differs between acutely and chronically HIV-infected patients

artículo científico publicado en 2012

Prevention of HIV-1 infection with early antiretroviral therapy

artículo científico publicado en 2011

Primer ID Informs Next-Generation Sequencing Platforms and Reveals Preexisting Drug Resistance Mutations in the HIV-1 Reverse Transcriptase Coding Domain

artículo científico publicado en 2015

Probability of heterosexual transmission of HIV

scientific article published on 01 January 1997

Prolonged therapy with the fusion inhibitor T-20 in combination with oral antiretroviral agents in an HIV-infected individual

artículo científico publicado en 1999

Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy.

artículo científico publicado en 2007

Quality control of HIV cultures in a clinical retrovirology laboratory

artículo científico publicado en 1996

Quantification of HIV in semen: correlation with antiviral treatment and immune status

artículo científico publicado en 1997

Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: comparison of NASBA with Amplicor reverse transcription-PCR amplification and correlation with quantitative culture

artículo científico publicado en 1996

R5 Macrophage-Tropic HIV-1 in the Male Genital Tract

artículo científico publicado en 2015

Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials Participants.

artículo científico publicado en 2017

Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial.

artículo científico publicado en 2011

Raltegravir pharmacokinetics in treatment-naive patients is not influenced by race: results from the raltegravir early therapy in African-Americans living with HIV (REAL) study

artículo científico publicado en 2012

Randomised trial of MNrgp120 HIV-1 vaccine in symptomless HIV-1 infection

scientific article published on 01 December 1996

Randomized Clinical Trial to Assess the Impact of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 on HIV-1 Persistence in Individuals on Effective ART

article

Randomized Controlled Pilot Study of Antiretrovirals and a Behavioral Intervention for Persons With Acute HIV Infection: Opportunity for Interrupting Transmission

article

Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population

artículo científico publicado en 2002

Real-world efficacy of direct acting antiviral therapies in patients with HIV/HCV

scientific article published on 13 February 2020

Recent abacavir use increases risk for Types 1 and 2 myocardial infarctions among adults with HIV.

artículo científico publicado en 2018

Recent cancer incidence trends in an observational clinical cohort of HIV-infected patients in the US, 2000 to 2011

artículo científico publicado en 2013

Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meeting

artículo científico publicado en 2019

Recruitment of HIV/AIDS treatment-naïve patients to clinical trials in the highly active antiretroviral therapy era: influence of gender, sexual orientation and race

artículo científico publicado en 2010

Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections

artículo científico publicado en 2011

Reduction in AIDS defining events/deaths with etravirine (ETR; TMC125) compared to placebo: pooled DUET 48-week results

article

Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1

scientific article published in The Lancet

Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group

article

Reductions in HIV-1 disease progression for zidovudine/lamivudine relative to control treatments: a meta-analysis of controlled trials

scientific article published on 01 March 1997

Regimen selection in the OPTIONS trial of HIV salvage therapy: drug resistance, prior therapy, and race-ethnicity determine the degree of regimen complexity

artículo científico publicado en 2015

Relationship of immunologic response to antiretroviral therapy with non-AIDS defining cancer incidence

artículo científico publicado en 2014

Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials

artículo científico publicado en 2019

Repeat testing of low-level HIV-1 RNA: assay performance and implementation in clinical trials

artículo científico publicado en 2018

Reply to P. De Paoli et al.

artículo científico publicado en 2014

Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years

artículo científico publicado en 2001

Residual plasma viraemia and infectious HIV-1 recovery from resting memory CD4 cells in patients on antiretroviral therapy: results from ACTG A5173.

artículo científico publicado en 2013

Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission

artículo científico publicado en 1998

Resistance to 2',3'-dideoxycytidine conferred by a mutation in codon 65 of the human immunodeficiency virus type 1 reverse transcriptase

artículo científico publicado en 1994

Resistance to HIV integrase strand transfer inhibitors among clinical specimens in the United States, 2009-2012.

scientific article published on 21 October 2013

Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada

artículo científico publicado en 2015

Rising prevalence of non-B HIV-1 subtypes in North Carolina and evidence for local onward transmission

artículo científico publicado en 2017

Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection

artículo científico publicado en 2010

Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care

artículo científico publicado en 2012

Risk factors for delayed antiretroviral therapy initiation among HIV-seropositive patients.

artículo científico publicado en 2017

Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening

artículo científico publicado en 2011

Risk of End-Stage Renal Disease in HIV-Positive Potential Live Kidney Donors.

artículo científico publicado en 2017

Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patients

artículo científico publicado en 2002

Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING Study

artículo científico publicado en 2012

Safety and efficacy of ombitasvir - 450/r and dasabuvir and ribavirin in HCV/HIV-1 co-infected patients receiving atazanavir or raltegravir ART regimens

artículo científico publicado en 2014

Safety of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in HIV-1-infected adults with end-stage renal disease on chronic haemodialysis: an open-label, single-arm, multicentre, phase 3b trial

artículo científico publicado en 2018

Safety of enfuvirtide in combination with an optimized background of antiretrovirals in treatment-experienced HIV-1-infected adults over 48 weeks

artículo científico publicado en 2005

Safety, tolerability, and efficacy of raltegravir in a diverse cohort of HIV-infected patients: 48-week results from the REALMRK Study ⬇️

artículo científico publicado en 2013

Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial

article

Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline

artículo científico publicado en 2010

Selection Bias Due to Loss to Follow Up in Cohort Studies

artículo científico publicado en 2015

Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy

artículo científico publicado en 2020

Self‐report of current and prior antiretroviral drug use in comparison to the medical record among HIV‐infected patients receiving primary HIV care ⬇️

artículo científico publicado el 3 de febrero de 2011

Sensitive method for the detection of infectious HIV in semen of seropositive individuals

artículo científico publicado en 1996

Sensitivity Analyses for Misclassification of Cause of Death in the Parametric G-Formula

artículo científico publicado en 2018

Seven-year efficacy of a lopinavir/ritonavir-based regimen in antiretroviral-naïve HIV-1-infected patients

artículo científico publicado en 2008

Severe postvaccinia encephalitis with acute disseminated encephalomyelitis: recovery with early intravenous immunoglobulin, high-dose steroids, and vaccinia immunoglobulin

artículo científico publicado en 2009

Sexual transmission during the incubation period of primary HIV infection

scientific article published on 01 October 2001

Sexual transmission of HIV: infectiousness and prevention

artículo científico publicado en 1999

Sexually transmitted infections among patients with acute HIV in North Carolina

scientific article published on June 2009

Shedding of HIV-1 in semen during primary infection

scientific article published on 01 March 1997

Short communication: lack of occult HIV infection among non-AIDS-defining cancer patients in three academic oncology clinics in the United States

artículo científico publicado en 2013

Short-term safety and antiretroviral activity of T-1249, a second-generation fusion inhibitor of HIV.

artículo científico publicado en 2004

Short-term safety and pharmacodynamics of amdoxovir in HIV-infected patients

artículo científico publicado en 2005

Significant decline in heavily treatment experienced persons with HIV with limited antiretroviral treatment options in the US, 2000-2017

scientific article published on 12 October 2020

Simplifying antiretroviral therapy

artículo científico publicado en 2004

Simultaneous determination of lamivudine and zidovudine concentrations in human seminal plasma using high-performance liquid chromatography and tandem mass spectrometry

artículo científico publicado en 2000

Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up

artículo científico publicado en 1998

Six-week randomized controlled trial to compare the tolerabilities, pharmacokinetics, and antiviral activities of GW433908 and amprenavir in human immunodeficiency virus type 1-infected patients

artículo científico publicado en 2004

Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine ⬇️

artículo científico publicado el 7 de noviembre de 2003

Smoking and predictors of pneumonia among HIV-infected patients receiving care in the HAART era.

artículo científico publicado en 2008

Social network-based recruitment successfully reveals HIV-1 transmission networks among high-risk individuals in El Salvador

artículo científico publicado en 2013

Social support and delays seeking care after HIV diagnosis, North Carolina, 2000-2006.

artículo científico publicado en 2009

Spatial epidemiology of recently acquired HIV infections across rural and urban areas of North Carolina

artículo científico publicado en 2014

Splines for trend analysis and continuous confounder control.

artículo científico publicado en 2011

Stable Caloric Intake and Continued Virologic Suppression for HIV-Positive Antiretroviral Treatment-Experienced Women After Switching to a Single-Tablet Regimen of Emtricitabine, Rilpivirine, and Tenofovir Disoproxil Fumarate.

artículo científico publicado en 2018

Substance abuse and symptoms of mental illness among HIV-positive persons in the Southeast.

artículo científico publicado en 2005

Survival in women exposed to single-dose nevirapine for prevention of mother-to-child transmission of HIV: a stochastic model

artículo científico publicado en 2007

Susceptibility testing by polymerase chain reaction DNA quantitation: a method to measure drug resistance of human immunodeficiency virus type 1 isolates ⬇️

artículo científico publicado el 15 de abril de 1992

Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials

artículo científico publicado en 2010

Synergistic inhibition of replication of human immunodeficiency virus type 1, including that of a zidovudine-resistant isolate, by zidovudine and 2',3'-dideoxycytidine in vitro ⬇️

artículo científico publicado el 1 de julio de 1992

Systemically circulating viral and tumor-derived microRNAs in KSHV-associated malignancies.

artículo científico publicado en 2013

T cells establish and maintain CNS viral infection in HIV-infected humanized mice

artículo científico publicado en 2018

T cells with high PD-1 expression are associated with lower HIV-specific immune responses despite long-term antiretroviral therapy

artículo científico publicado en 2020

T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy

artículo científico publicado en 2017

TORO: ninety-six-week virologic and immunologic response and safety evaluation of enfuvirtide with an optimized background of antiretrovirals

artículo científico

Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial

scientific article published on 01 June 2020

Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era.

artículo científico publicado en 2013

Ten Years of Screening and Testing for Acute HIV Infection in North Carolina

artículo científico publicado en 2016

Ten-year Survival by Race/Ethnicity and Sex Among Treated, HIV-infected Adults in the United States.

artículo científico publicado en 2015

The Impact of Implementation Fidelity on Mortality Under a CD4-Stratified Timing Strategy for Antiretroviral Therapy in Patients With Tuberculosis

artículo científico publicado en 2015

The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial

artículo científico publicado en 2006

The Role of Current and Historical Alcohol Use in Hepatic Fibrosis Among HIV-Infected Individuals

artículo científico publicado en 2017

The authors reply

artículo científico publicado en 2014

The design of single-arm clinical trials of combination antiretroviral regimens for treatment-naive HIV-infected patients

artículo científico publicado en 2013

The detection and management of early HIV infection: a clinical and public health emergency

artículo científico publicado en 2013

The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration

artículo científico publicado en 1999

The effect of antiretroviral therapy on all-cause mortality, generalized to persons diagnosed with HIV in the USA, 2009-11.

artículo científico publicado en 2016

The effect of lamivudine therapy and M184V on the antiretroviral activity of didanosine

artículo científico publicado en 2007

The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial

artículo científico publicado en 2010

The effect of tuberculosis treatment on virologic and CD4+ cell count response to combination antiretroviral therapy: a systematic review

artículo científico publicado en 2014

The effects of protease inhibitor therapy on human immunodeficiency virus type 1 levels in semen (AIDS clinical trials group protocol 850).

artículo científico publicado en 2000

The frequency of malaria is similar among women receiving either lopinavir/ritonavir or nevirapine-based antiretroviral treatment

artículo científico publicado en 2012

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

artículo científico publicado en 2010

The pharmacokinetics of amprenavir, zidovudine, and lamivudine in the genital tracts of men infected with human immunodeficiency virus type 1 (AIDS clinical trials group study 850).

artículo científico publicado en 2002

The pharmacokinetics, safety, and initial virologic response of a triple-protease inhibitor salvage regimen containing amprenavir, saquinavir, and ritonavir

artículo científico publicado en 2004

The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy

artículo científico publicado en 2009

The relationship between efavirenz as initial antiretroviral therapy and suicidal thoughts among HIV-infected adults in routine care

artículo científico publicado en 2017

The role of at-risk alcohol/drug use and treatment in appointment attendance and virologic suppression among HIV(+) African Americans

artículo científico publicado en 2014

The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults.

artículo científico publicado en 2002

The treatment of antiretroviral-naive subjects with the 3TC/zidovudine combination: a review of North American (NUCA 3001) and European (NUCB 3001) trials.

artículo científico publicado en 1996

Total daily pill burden in HIV-infected patients in the southern United States

artículo científico publicado en 2014

Transcriptional Changes in CD8(+) T Cells During Antiretroviral Therapy Intensified With Raltegravir

artículo científico publicado en 2015

Transmitted antiretroviral drug resistance among acute and recent HIV infections in North Carolina from 1998 to 2007

artículo científico publicado en 2009

Treatment responses in antiretroviral treatment-naive premenopausal and postmenopausal HIV-1-infected women: an analysis from AIDS Clinical Trials Group Studies

artículo científico publicado en 2009

Treatment with amprenavir alone or amprenavir with zidovudine and lamivudine in adults with human immunodeficiency virus infection. AIDS Clinical Trials Group 347 Study Team.

artículo científico publicado en 1999

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

artículo científico publicado en 1997

Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party

artículo científico publicado en 1995

Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America

artículo científico publicado en 2009

Triple-class antiretroviral drug resistance: risk and predictors among HIV-1-infected patients

scientific article published on 01 April 2007

Two-Drug Combinations of Zidovudine, Didanosine, and Recombinant Interferon- A Inhibit Replication of Zidovudine-Resistant Human Immunodeficiency Virus Type 1 Synergistically In Vitro ⬇️

artículo científico publicado el 1 de octubre de 1991

Types of Myocardial Infarction Among Human Immunodeficiency Virus-Infected Individuals in the United States

artículo científico publicado en 2017

US Black Women and Human Immunodeficiency Virus Prevention: Time for New Approaches to Clinical Trials

artículo científico publicado en 2017

Unexpected finding of delayed-onset seizures in HIV-positive, treatment-experienced subjects in the Phase IIb evaluation of fosdevirine (GSK2248761).

artículo científico publicado en 2013

Unmet therapeutic needs in the new era of combination antiretroviral therapy for HIV-1.

scientific article published on 25 March 2010

Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy ⬇️

artículo científico publicado el 18 de febrero de 1993

Using Primer-ID Deep Sequencing to Detect Recent Human Immunodeficiency Virus Type 1 Infection

scholarly article by Ann M Dennis et al published 20 October 2018 in Journal of Infectious Diseases

Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy

artículo científico publicado en 2015

Validation of Medicaid Claims-based Diagnosis of Myocardial Infarction Using an HIV Clinical Cohort

artículo científico publicado en 2015

Validation of a brief screening instrument for substance abuse and mental illness in HIV-positive patients.

artículo científico publicado en 2005

Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells

artículo científico publicado en 2008

Variability of the date of HIV diagnosis: a comparison of self-report, medical record, and HIV/AIDS surveillance data

artículo científico publicado en 2010

Vasculitic and encephalitic complications associated with Coccidioides immitis infection of the central nervous system in humans: report of 10 cases and review

artículo científico publicado el 1 de marzo de 1992

Viral Failure Among Persons Living with HIV Initiating Dolutegravir-Based vs. Other Recommended Regimens in Real-World Clinical Care Settings.

artículo científico publicado en 2017

Viral Hepatitis among HIV+ Patients in Northern Vietnam.

artículo científico publicado en 2017

Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model

artículo científico publicado en 2001

Viral suppression in HIV studies: combining times to suppression and rebound

artículo científico publicado en 2014

Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy

artículo científico publicado en 2011

Virologic Failure Among People Living With HIV Initiating Dolutegravir-Based Versus Other Recommended Regimens in Real-World Clinical Care Settings

artículo científico publicado en 2019

Virologic outcomes in early antiretroviral treatment: HPTN 052.

artículo científico publicado en 2017

Virologic response, early HIV-1 decay, and maraviroc pharmacokinetics with the nucleos(t)ide-free regimen of maraviroc plus darunavir/ritonavir in a pilot study

artículo científico publicado en 2013

Virologic suppression and CD4+ cell count recovery after initiation of raltegravir or efavirenz-containing HIV treatment regimens

artículo científico publicado en 2017

Week 48 Results of EMERALD: A Phase 3, Randomized, Non-inferiority Study Evaluating the Efficacy and Safety of Switching from Boosted-protease Inhibitors (bPI) Plus Emtricitabine (FTC)/Tenofovir Disoproxil Fumarate (TDF) Regimens to the Once Daily (

artículo científico publicado en 2017

Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobic

scientific article published on 04 July 2019

Week 96 results of a phase 3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients

scientific article published on 01 April 2020

Weight gain following antiretroviral therapy (ART) initiation in ART-naïve people living with HIV in the current treatment era

artículo científico publicado en 2020

When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational Study

artículo científico publicado en 2016

pol mutations conferring zidovudine and didanosine resistance with different effects in vitro yield multiply resistant human immunodeficiency virus type 1 isolates in vivo

artículo científico publicado en 1993

Lista de obras de

14th annual retrovirus conference (CROI). One-on-one with Joseph J. Eron, MD. Interview by Jeff Berry

1768. Efficacy and Safety of Switching From Boosted-Protease Inhibitors (bPI) Plus Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) Regimens to the Once Daily (QD), Single-Tablet Regimen (STR) of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafen

2490. Longer-Term Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed Adults Living With HIV and End-Stage Renal Disease on Chronic Hemodialysis

2503. Differences Between Experts and Community Clinicians in Selecting HIV Switch Regimens for Patients With Viral Suppression

3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine

550. Adherence and Persistency With Modern Single vs. Multi-Tablet Antiretroviral (ARV) Regimens in First Treatment of HIV in Clinical Practice

A 42-week open-label study to assess the pharmacokinetics, antiretroviral activity, and safety of amprenavir or amprenavir plus ritonavir in combination with abacavir and lamivudine for treatment of HIV-infected patients

A brief mental health and substance abuse screener for persons with HIV.

A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II).

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

A novel codon insert in protease of clade B HIV type 1.

A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy

A phase II trial of dual protease inhibitor therapy: amprenavir in combination with indinavir, nelfinavir, or saquinavir

A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease

A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavir.

A week 48 randomized phase 3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve HIV-1 patients.

ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results.

Aciclovir treatment for human immunodeficiency virus-1: is the “juice worth the squeeze?”.

Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961).

Activity, safety, and immunological effects of hydroxyurea added to didanosine in antiretroviral-naive and experienced HIV type 1-infected subjects: a randomized, placebo-controlled trial, ACTG 307.

Acute HIV Infection and CD4/CD8 Ratio Normalization After Antiretroviral Therapy Initiation

Acute HIV revisited: new opportunities for treatment and prevention

Acute HIV revisited: new opportunities for treatment and prevention.

Acute HIV-1 infection in the Southeastern United States: a cohort study

Addition of 7 Days of Zidovudine Plus Lamivudine to Peripartum Single-Dose Nevirapine Effectively Reduces Nevirapine Resistance Postpartum in HIV-Infected Mothers in Malawi ⬇️

Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

Advanced immunosuppression at entry to HIV care in the southeastern United States and associated risk factors

Advances in antiretroviral therapy

African American race and HIV virological suppression: beyond disparities in clinic attendance

Age at Entry Into Care, Timing of Antiretroviral Therapy Initiation, and 10-Year Mortality Among HIV-Seropositive Adults in the United States

Age at antiretroviral therapy initiation predicts immune recovery, death, and loss to follow-up among HIV-infected adults in urban Zambia

Age trends in the prevalence of cervical squamous intraepithelial lesions among HIV-positive women in Cameroon: a cross-sectional study

Alternative strategies for anti-HIV treatment

Amino-terminal alteration of the HLA-A*0201-restricted human immunodeficiency virus pol peptide increases complex stability and in vitro immunogenicity

An HIV self-care symptom management intervention for African American mothers

Analysis of BENCHMRK 1 & 2 using PhenoSense® assay for darunavir (DRV/r) resistance and exploration of functional monotherapy with RAL vs DRV.

Analysis of virological efficacy in trials of antiretroviral regimens: drawbacks of not including viral load measurements after premature discontinuation of therapy

Anemia risk factors among people living with HIV across the United States in the current treatment era: a clinical cohort study

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel

Antiretroviral Therapy for the Prevention of HIV-1 Transmission

Antiretroviral activity and safety of once-daily etravirine in treatment-naive HIV-infected adults: 48-week results

Antiretroviral drug class and anaemia risk in the current treatment era among people living with HIV in the USA: a clinical cohort study

Antiretroviral drug resistance in HIV-1-infected patients experiencing persistent low-level viremia during first-line therapy

Antiretroviral intensification and valproic acid lack sustained effect on residual HIV-1 viremia or resting CD4+ cell infection

Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T-cell activation

Antiretroviral therapy: new drugs, formulations, ideas, and strategies

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel

Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel.

Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel.

Antiretroviral-Drug Concentrations in Semen: Implications for Sexual Transmission of Human Immunodeficiency Virus Type 1.

Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1

Assessing and Refining Myocardial Infarction Risk Estimation Among Patients With Human Immunodeficiency Virus: A Study by the Centers for AIDS Research Network of Integrated Clinical Systems

Assessing the impact of AGS-004, a dendritic cell-based immunotherapy, and vorinostat on persistent HIV-1 Infection

Association Between Bilirubin, Atazanavir, and Cardiovascular Disease Events Among People Living With HIV Across the United States

Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data

Association between first-year virological response to raltegravir and long-term outcomes in treatment-experienced patients with HIV-1 infection

Association of CD4 cell depletion and elevated blood and seminal plasma human immunodeficiency virus type 1 (HIV-1) RNA concentrations with genital ulcer disease in HIV-1-infected men in Malawi

Association of early HIV viremia with mortality after HIV-associated lymphoma

Association of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected subjects with prior nucleoside analog experience

Associations Between At-Risk Alcohol Use, Substance Use, and Smoking with Lipohypertrophy and Lipoatrophy Among Patients Living with HIV.

Associations of T cell activation and inflammatory biomarkers with virological response to darunavir/ritonavir plus raltegravir therapy

Attrition among human immunodeficiency virus (HIV)- infected patients initiating antiretroviral therapy in China, 2003-2010

Barriers and facilitators to HIV testing and linkage to primary care: narratives of people with advanced HIV in the Southeast

Beyond core indicators of retention in HIV care: missed clinic visits are independently associated with all-cause mortality

Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events

Brief Report: HIV Antibodies Decline During Antiretroviral Therapy but Remain Correlated With HIV DNA and HIV-Specific T-Cell Responses

Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial

Brief Report: Longitudinal Opioid Use Among HIV-Infected Patients, 2000 to 2014.

Brief Report: No Evidence for an Association Between Statin Use and Lower Biomarkers of HIV Persistence or Immune Activation/Inflammation During Effective ART

Brief Report: Reduced Use of Illicit Substances, Even Without Abstinence, Is Associated With Improved Depressive Symptoms Among People Living With HIV

Brief Report: Virologic Response by Baseline Viral Load With Dolutegravir Plus Lamivudine vs Dolutegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine: Pooled Analysis

Brief but efficient: acute HIV infection and the sexual transmission of HIV.

CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals

CD4 count at entry into HIV care and at antiretroviral therapy prescription in the US, 2005-2018

CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?

CD4+CD8+ T cells represent a significant portion of the anti-HIV T cell response to acute HIV infection

Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women